- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Mackie Research Initiates Coverage of Harvest One Cannabis
Mackie Research has initiated coverage of Harvest One Cannabis (TSXV:HVST).
Mackie Research has initiated coverage of Harvest One Cannabis (TSXV:HVST), a Canada-based cannabis company with properties in BC and Saskatchewan that is in the process of obtaining its sales license.
“[Mackie Research] Analyst Greg McLeish gives the company a buy rating and a 12-month target price of $1.00, a premium of 45% to the $0.69 price on September 20th, the day the report was issued.”
Harvest One’s flagship property in Duncan, BC sits on 13 acres of land and boasts a production rate of 1,000 kilograms a year. McLeish anticipates that Harvest One should have its sales license within 60 days of when the report was issued.
Click here to connect with Harvest One Cannabis (TSXV:HVST) for an Investor Presentation.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.